Skip to content

Clinical trials

Phase 3 Glomerulonephritis, IGA trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glomerulonephritis, IGA Phase: Phase 3 Country / region: Australia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20183
20202
20212
20221
20232
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting6
Completed4
Recruiting4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
Calliditas Therapeutics AB2
Alexion Pharmaceuticals, Inc.1
Alpine Immune Sciences Inc, A Subsidiary of Vertex1
Biogen1
Hoffmann-La Roche1
Omeros Corporation1
Otsuka Pharmaceutical Development & Commercialization, Inc.1
Travere Therapeutics, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glomerulonephritis, IGA15
Renal Insufficiency, Chronic6
Glomerulonephritis5
Proteinuria4
Kidney Diseases3
Urologic Diseases3
Autoimmune Diseases1
Female Urogenital Diseases1
Female Urogenital Diseases and Pregnancy Complications1
Immune System Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.